Immunonutrition improves functional capacities in head and neck and esophageal cancer patients undergoing radiochemotherapy: A randomized clinical trial

Clinical Nutrition

Volumn 33, Issue 2, 2014, Pages 204-210

  Vasson, M P ^a,b   Talvas, J ^b   Perche, O ^b   Dillies, A F ^c   Bachmann, P ^d   Pezet, D ^a   Achim, A C ^a   Pommier, P ^d   Racadot, S ^d   Weber, A ^e   Ramdani, M ^e   Kwiatkowski, F ^c   Bouteloup, C ^a,b  

^a UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c CENTRE JEAN PERRIN   (France)

^d CENTRE LÉON BÉRARD   (France)

^e CH Béziers Service de Gastro Entérologie   (France)

Author keywords

Esophageal cancer; Head and neck cancer; Immunonutrition; Radiochemotherapy

Indexed keywords

ALBUMIN; ANTIOXIDANT; ARGININE; CISPLATIN; FLUOROURACIL; NUCLEOTIDE; OMEGA 3 FATTY ACID;

ADULT; ALBUMIN BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; ENTERIC FEEDING; ESOPHAGUS CANCER; FEMALE; FUNCTIONAL STATUS; HEAD AND NECK CANCER; HUMAN; IMMUNOMODULATION; IMMUNONUTRITION; MALE; MALNUTRITION; MULTICENTER STUDY; NUTRITIONAL STATUS; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; WEIGHT GAIN;

ESOPHAGEAL CANCER; HEAD AND NECK CANCER; IMMUNONUTRITION; RADIOCHEMOTHERAPY;

AGED; ANTHROPOMETRY; ARGININE; C-REACTIVE PROTEIN; CHEMORADIOTHERAPY; DOUBLE-BLIND METHOD; ENTERAL NUTRITION; ESOPHAGEAL NEOPLASMS; FATTY ACIDS, MONOUNSATURATED; FATTY ACIDS, UNSATURATED; FEMALE; FOOD, FORMULATED; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOMODULATION; INTERVENTION STUDIES; MALE; MIDDLE AGED; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; SERUM ALBUMIN; TREATMENT OUTCOME;

EID: 84895436236     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.06.008     Document Type: Article

References (31)

1. Mekhail T.M., Adelstein D.J., Rybicki L.A., Larto M.A., Saxton J.P., Lavertu P. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous endoscopic gastrostomy tube preferable to a nasogastric tube?. Cancer 2001 May 1, 91(9):1785-1790.
2. Larrea J., Vega S., Martinez T., Torrent J.M., Vega V., Nunez V. The nutritional status and immunological situation of cancer patients. Nutr Hosp 1992 May-Jun, 7(3):178-184.
3. Chasen M.R., Bhargava R. A descriptive review of the factors contributing to nutritional compromise in patients with head and neck cancer. Support Care Cancer 2009 Nov, 17(11):1345-1351.
4. Andreyev H.J., Norman A.R., Oates J., Cunningham D. Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies?. Eur J Cancer 1998 Mar, 34(4):503-509.
5. Capuano G., Gentile P.C., Bianciardi F., Tosti M., Palladino A., Di Palma M. Prevalence and influence of malnutrition on quality of life and performance status in patients with locally advanced head and neck cancer before treatment. Support Care Cancer 2010 Apr, 18(4):433-437.
6. van Bokhorst-de van der Schueren M.A., van Leeuwen P.A., Kuik D.J., Klop W.M., Sauerwein H.P., Snow G.B., et al. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 1999 Aug 1, 86(3):519-527.
7. Langer C.J., Hoffman J.P., Ottery F.D. Clinical significance of weight loss in cancer patients: rationale for the use of anabolic agents in the treatment of cancer-related cachexia. Nutrition 2001 Jan, 17(1 Suppl.):S1-S20.
8. Choong N., Vokes E. Expanding role of the medical oncologist in the management of head and neck cancer. CA Cancer J Clin 2008 Jan-Feb, 58(1):32-53.
9. Fung K., Lyden T.H., Lee J., Urba S.G., Worden F., Eisbruch A., et al. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 2005 Dec 1, 63(5):1395-1399.
10. Arends J., Bodoky G., Bozzetti F., Fearon K., Muscaritoli M., Selga G., et al. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr 2006 Apr, 25(2):245-259.
11. Paccagnella A., Morello M., Da Mosto M.C., Baruffi C., Marcon M.L., Gava A., et al. Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy. Support Care Cancer 2010 Jul, 18(7):837-845.
12. Takagi K., Yamamori H., Furukawa K., Miyazaki M., Tashiro T. Perioperative supplementation of EPA reduces immunosuppression induced by postoperative chemoradiation therapy in patients with esophageal cancer. Nutrition 2001 Jun, 17(6):478-479.
13. Shintani Y., Ikeda N., Matsumoto T., Kadota Y., Okumura M., Ohno Y., et al. Nutritional status of patients undergoing chemoradiotherapy for lung cancer. Asian Cardiovasc Thorac Ann 2012 Apr, 20(2):172-176.
14. Machon C., Thezenas S., Dupuy A.M., Assenat E., Michel F., Mas E., et al. Immunonutrition before and during radiochemotherapy: improvement of inflammatory parameters in head and neck cancer patients. Support Care Cancer 2012 Mar 28, 20(12):3129-3135.
15. Santora R., Kozar R.A. Molecular mechanisms of pharmaconutrients. J Surg Res 2010 Jun 15, 161(2):288-294.
16. Kwiatkowski F., Girard M., Hacene K., Berlie J. Sem: a suitable statistical software adaptated for research in oncology. Bull Cancer 2000 Oct, 87(10):715-721.
17. Merlin E., Goncalves-Mendes N., Hannani D., de la Torre A., Farges M.C., Laroye H., et al. Extracorporeal photochemotherapy induces arginase 1 in patients with graft versus host disease. Transpl Immunol 2011 Jan 15, 24(2):100-106.
18. Tardy A.L., Giraudet C., Rousset P., Rigaudiere J.P., Laillet B., Chalancon S., et al. Effects of trans MUFA from dairy and industrial sources on muscle mitochondrial function and insulin sensitivity. J Lipid Res 2008 Jul, 49(7):1445-1455.
19. Oken M.M., Creech R.H., Tormey D.C., Horton J., Davis T.E., McFadden E.T., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982 Dec, 5(6):649-655.
20. Karnosky D.A., Burchenal B.H. The clinical evaluation of chemotherapeutic agents in cancer. Evaluation of chemotherapeutic agents 1949, 191-205. Columbia University Press, New-York. C.M. MacLeod (Ed.).
21. Trotti A., Bellm L.A., Epstein J.B., Frame D., Fuchs H.J., Gwede C.K., et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003 Mar, 66(3):253-262.
22. Capuano G., Grosso A., Gentile P.C., Battista M., Bianciardi F., Di Palma A., et al. Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck 2008 Apr, 30(4):503-508.
23. Popovic P.J., Zeh H.J., Ochoa J.B. Arginine and immunity. J Nutr 2007 Jun, 137(6 Suppl. 2):1681S-1686S.
24. Murphy R.A., Mourtzakis M., Chu Q.S., Baracos V.E., Reiman T., Mazurak V.C. Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer. Cancer 2011 Aug 15, 117(16):3774-3780.
25. Calder P.C., Dangour A.D., Diekman C., Eilander A., Koletzko B., Meijer G.W., et al. Essential fats for future health. Proceedings of the 9th Unilever nutrition symposium, 26-27 May 2010. Eur J Clin Nutr 2010 Dec, 64(Suppl. 4):S1-S13.
26. Grimble G.K., Westwood O.M. Nucleotides as immunomodulators in clinical nutrition. Curr Opin Clin Nutr Metab Care 2001 Jan, 4(1):57-64.
27. Proctor M.J., Morrison D.S., Talwar D., Balmer S.M., O'Reilly D.S., Foulis A.K., et al. An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer 2011 Feb 15, 104(4):726-734.
28. Durken M., Herrnring C., Finckh B., Nagel S., Nielsen P., Fischer R., et al. Impaired plasma antioxidative defense and increased nontransferrin-bound iron during high-dose chemotherapy and radiochemotherapy preceding bone marrow transplantation. Free Radic Biol Med 2000 Mar 15, 28(6):887-894.
29. Roth E., Manhart N., Wessner B. Assessing the antioxidative status in critically ill patients. Curr Opin Clin Nutr Metab Care 2004 Mar, 7(2):161-168.
30. Bohn SK, Russnes KM, Sakhi AK, Thoresen M, Holden M, Moskaug JO, et al. Stress associated gene expression in blood cells is related to outcome in radiotherapy treated head and neck cancer patients. BMC Cancer;12:426.
31. Dewys W.D., Begg C., Lavin P.T., Band P.R., Bennett J.M., Bertino J.R., et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980 Oct, 69(4):491-497.